PT Journal
AU Zatloukalova, A
   Homza, M
   Kovalova, M
TI Patient life style with anti-coagulation treatment: first results of the pilot study
SO Profese Online
PY 2020
BP 46
EP 55
VL 13
IS 1
DI 10.5507/pol.2020.010
DE risk factors; prevention; cardiovaskular diseases; livestyle
AB Background: Lifestyle is an important risk factor for many, especially non-infectious diseases such as cardiovascular diseases. These are diseases with a long-term high incidence and mortality in the Czech Republic and abroad. They are often very preventable. Anticoagulants reduce pathologically increased blood coagulation in many of these diseases. In addition to the most commonly used Warfarin, we now have new direct oral anticoagulants (Pradaxa, Xarelto, Eliquis, Lixiana). Objective: The aim of the pilot study is to obtain valuable information about the lifestyle of patients receiving anticoagulant treatment. Methods: The information was collected through a questionnaire survey. The questionnaire was compiled on the basis of standardised questions used in large population epidemiological studies. Results: The average body mass index (BMI) was in the obesity zone. Men were more in the area of overweight, women in the obesity zone. The most common comorbidity was hypertension and diabetes mellitus II. Type. More than half of them were not comprehensively educated in the area of healthy lifestyle, a quarter were not educated at all. According to the CHA2DS2-VASc score, patients were at high risk of thromboembolism (score ≥ 2). Conclusions: Lifestyle remains one of the most important and often very preventable factors that act not only as a risk but also as a prevention of many cardiovascular diseases, including those requiring anticoagulant therapy.
ER